Evidence map›Paper›PMID 41961651›Full record

ReviewMedicine2026

The diagnostic and therapeutic challenges of pulmonary epithelioid trophoblastic tumor: A case report and literature review.

Zhuo Yang, Shufang Chang, Jiangchuan Sun, Qianqian Wang

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhuo YangDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Shufang Chang
Jiangchuan Sun

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationalePrimary pulmonary epithelioid trophoblastic tumor (ETT) without a uterine primary is exceptionally rare, with merely 29 cases documented in the English-language literature. Therefore, a standardized management protocol has yet to be established, and the optimal treatment strategy remains poorly defined. PATIENT CONCERNS: A 31-year-old woman presented to a local hospital with irregular vaginal bleeding and was initially diagnosed with an ectopic pregnancy due to elevated serum beta-human chorionic gonadotropin (β-hCG) levels. Following treatment with diagnostic curettage and methotrexate, her β-hCG levels plateaued. The patient was subsequently referred to our institution for further investigation. Imaging revealed a 1.7 cm × 1.5 cm pulmonary nodule, which was initially suspected to be peripheral lung cancer. DIAGNOSES: Video-assisted thoracoscopic resection and subsequent histopathological analysis confirmed the diagnosis of ETT.

interventionsThe patient received 4 cycles of combined EMA/EP (etoposide, methotrexate, actinomycin D/etoposide, cisplatin) chemotherapy after the surgery. OUTCOMES: During 3 years of follow-up, her menstrual cycles were normal and there was no evidence of disease recurrence. LESSONS: This case highlights the diagnostic challenges and management strategies for pulmonary ETT, particularly in preserving fertility while ensuring optimal oncological outcomes.

Indexed as

Lung NeoplasmsTrophoblastic NeoplasmsAdultAntineoplastic Combined Chemotherapy ProtocolsChorionic Gonadotropin, beta Subunit, HumanCisplatinDactinomycinEpithelioid CellsEtoposideFemaleHumansMethotrexatePregnancyThoracic Surgery, Video-AssistedChorionic Gonadotropin, beta Subunit, HumanCisplatinDactinomycinEtoposideMethotrexateepithelioid trophoblastic tumorfertility preservationgestational trophoblastic neoplasmlung cancermisdiagnosis

Identifiers

PMID41961651
PMCPMC13592941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.